# FDA staff told the panelists they recommended against giving compounders the green light due to a lack of clinical…
*Canonical page:* https://truthscore.com/claim/fda-staff-told-the-panelists-they-recommended-against-giving--ea295a13
*Numbers under lens:* **Evidence-weighted** (`log-odds@1`)
*Machine twins:* https://truthscore.com/claim/fda-staff-told-the-panelists-they-recommended-against-giving--ea295a13.md · JSON at https://truthscore.com/api/v1
FDA staff told the panelists they recommended against giving compounders the green light due to a lack of clinical evidence demonstrating safety and efficacy.

## Voices

*Counted, never weighed.*

- [STAT](https://truthscore.com/entity/386551b8) — independent

## Sources

- [FDA advisory panel narrowly rejects compounding of one peptide, backs two others](https://truthscore.com/source/a99385d6)